Latest filing published 01 Mar 2023 for Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.), €2,614.
All filings by Mirza Dautbegovic on record concern Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). In total, 4 filings cover trades dated 27 February 2023.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The record was last updated on 1 March 2023 with a transaction (€2,614) in Bausch Health Companies Inc. (formerly, Valeant Pharmaceuticals International, Inc.). Between a trade and the moment it shows up on SEDI, the median delay is 2 days. That lag is the time during which only the insider knows about the trade. Source: insider filings from SEDI. Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
4 of 4 declarations